Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-202,620
Closed -$6.46M 32
2020
Q4
$6.46M Sell
202,620
-38,785
-16% -$1.05M 2.35% 25
2020
Q3
$5.35M Sell
241,405
-50,496
-17% -$1.15M 2.57% 23
2020
Q2
$6.92M Buy
+291,901
New +$6.05M 3.35% 15
2020
Q1
Sell
-240,077
Closed -$7.9M 42
2019
Q4
$7.9M Sell
240,077
-2,243
-0.9% -$66.2K 4.01% 10
2019
Q3
$6.13M Buy
242,320
+115,100
+90% +$2.71M 3.53% 12
2019
Q2
$3.3M Buy
127,220
+7,488
+6% +$261K 1.83% 24
2019
Q1
$4.52M Buy
+119,732
New +$5.48M 2.36% 22
2017
Q1
Sell
-184,602
Closed -$4.9M 42
2016
Q4
$4.9M Buy
184,602
+117,602
+176% +$3.51M 2.81% 21
2016
Q3
$2.48M Buy
+67,000
New +$2.48M 1.35% 31

Other funds holding NTNX

Nepsis Inc's NTNX Position: Q1 2021 in Review

Nepsis Inc sold out of Nutanix (NTNX) in Q1 2021, closing a stake of 202,620 shares — an estimated $6.46M sold.

Nepsis Inc first reported a position in NTNX in Q3 2016 and held it in 9 quarters. The position peaked at $7.9M in Q4 2019. 280 funds tracked by Wall St. Rank hold NTNX as of Q1 2021.

  • Nepsis Inc reported no remaining Nutanix position as of Q1 2021 after selling out during the quarter.
  • Nepsis Inc sold 202,620 Nutanix shares in Q1 2021, an estimated $6.46M.
  • Nepsis Inc first reported a position in Nutanix in Q3 2016 and held it in 9 quarters.
  • Nepsis Inc's Nutanix position peaked at $7.9M in Q4 2019.
  • 280 funds tracked by Wall St. Rank held Nutanix as of Q1 2021.

Based on Nepsis Inc's 13F filing for Q1 2021, filed 20 Apr 2021.